Cargando…
Omission of Chemotherapy for the Treatment of Mucinous Breast Cancer: A Nationwide Study from the Korean Breast Cancer Society
PURPOSE: Mucinous breast carcinoma (MBC) is a rare type of breast cancer. Although patients with MBC may have a better prognosis than that of patients with invasive ductal carcinoma, many clinicians administer adjuvant chemotherapy regimens similar to those for other breast tumors. Using data from a...
Autores principales: | Kim, Hyung Suk, Lee, Jong Uk, Yoo, Tae Kyung, Chae, Byung Joo, Son, Donghee, Kim, Yun Jin, Park, Woo Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933040/ https://www.ncbi.nlm.nih.gov/pubmed/31897333 http://dx.doi.org/10.4048/jbc.2019.22.e46 |
Ejemplares similares
-
Pattern of distant recurrence according to the molecular subtypes in Korean women with breast cancer
por: Park, Hyung Seok, et al.
Publicado: (2012) -
Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype(−) Breast Cancer
por: Kim, Hyung Suk, et al.
Publicado: (2019) -
Clinicopathological features and prognosis associated with breast cancer laterality: a nationwide study from the Korean Breast Cancer Society
por: Kim, Bong Kyun, et al.
Publicado: (2022) -
Omission of chemotherapy for hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: patterns of treatment and outcomes from the Korean Breast Cancer Society Registry
por: Kangleon-Tan, Hannah Lois, et al.
Publicado: (2022) -
Clinical Differences in Triple-Positive Operable Breast Cancer Subtypes in Korean Patients: An Analysis of Korean Breast Cancer Registry Data
por: You, Sun Hyong, et al.
Publicado: (2018)